Cargando…

EGFR/MET promotes hepatocellular carcinoma metastasis by stabilizing tumor cells and resisting to RTKs inhibitors in circulating tumor microemboli

The receptor tyrosine kinases (RTKs) family is well-recognized as vital targets for the treatment of hepatocarcinoma cancer (HCC) clinically, whereas the survival benefit of target therapy sorafenib is not satisfactory for liver cancer patients due to metastasis. EGFR and MET are two molecules of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Shouyang, Yu, Zhen, You, Yajing, Liu, Chenxi, Xie, Xiaoyu, Lv, Huanran, Xiao, Feng, Zhu, Qiang, Qin, Chengyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012802/ https://www.ncbi.nlm.nih.gov/pubmed/35428350 http://dx.doi.org/10.1038/s41419-022-04796-8

Ejemplares similares

Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer()
por: Zheng, Xiumei, et al.
Publicado: (2017)

New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma
por: Wan, Shanshan, et al.
Publicado: (2019)

Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions
por: Mascalchi, Mario, et al.
Publicado: (2017)

Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer
por: Chen, Yang, et al.
Publicado: (2021)

How Do Gangliosides Regulate RTKs Signaling?
por: Julien, Sylvain, et al.
Publicado: (2013)

Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection
por: Chen, Jia-Yang, et al.
Publicado: (2016)

Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9
por: Chu, Hsueh-Yao, et al.
Publicado: (2021)

CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor
por: Torres, Jacqueline Aparecida, et al.
Publicado: (2023)

HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis
por: Xie, Xiaoyu, et al.
Publicado: (2021)

Correction: HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis
por: Xie, Xiaoyu, et al.
Publicado: (2022)

Detection of Genomically Aberrant Cells within Circulating Tumor Microemboli (CTMs) Isolated from Early-Stage Breast Cancer Patients
por: Silvestri, Marco, et al.
Publicado: (2021)

On a mechanistic impact of transmembrane tetramerization in the pathological activation of RTKs
por: Polyansky, Anton A., et al.
Publicado: (2023)

Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy
por: Zhang, Dejun, et al.
Publicado: (2017)

A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer
por: Abdallah, Emne Ali, et al.
Publicado: (2020)

Endosomal binding kinetics of Eps15 and Hrs specifically regulate the degradation of RTKs
por: Haugen, Linda Hofstad, et al.
Publicado: (2017)

Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
por: Butti, Ramesh, et al.
Publicado: (2018)

Oesophagus cancer, secondary cardiac tumour, and pulmonary microemboli
por: Tanaka, Yutaka, et al.
Publicado: (2022)

Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
por: Azad, Taha, et al.
Publicado: (2020)

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness
por: Long, Elodie, et al.
Publicado: (2016)

Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer
por: Ema, Akira, et al.
Publicado: (2014)

Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?
por: Idicula, Titto T, et al.
Publicado: (2010)

The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma
por: Zhang, Yu, et al.
Publicado: (2018)

HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
por: Spina, Anna, et al.
Publicado: (2015)

MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway
por: Xu, Hui, et al.
Publicado: (2019)

Proteome-Wide Detection and Annotation of Receptor Tyrosine Kinases (RTKs): RTK-PRED and the TyReK Database
por: Filis, Georgios, et al.
Publicado: (2023)

Miliary microemboli of the retinal arterioles and choriocapillaris after subcutaneous injection of triamcinolone acetonide
por: Kayikcioglu, Ozcan Rasim, et al.
Publicado: (2018)

Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma
por: Yu, Jing, et al.
Publicado: (2021)

Metastasis and Circulating Tumor Cells
por: van Dalum, Guus, et al.
Publicado: (2012)

ORP5 promotes tumor metastasis via stabilizing c-Met in renal cell carcinoma
por: Song, Li, et al.
Publicado: (2022)

The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met(+) Hepatocellular Carcinoma
por: Steinway, Steven N., et al.
Publicado: (2015)

Role of Tissue Plasminogen Activator for Diffuse Pulmonary Microemboli in Coronavirus Disease 2019 Patient
por: Ghia, Samit, et al.
Publicado: (2021)

Localizing Microemboli within the Rodent Brain through Block-Face Imaging and Atlas Registration
por: McDonald, Matthew W., et al.
Publicado: (2021)

In vivo analysis of the origin and characteristics of gaseous microemboli during catheter-mediated irreversible electroporation
por: Groen, Marijn H A, et al.
Publicado: (2020)

Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells
por: Sun, Bin, et al.
Publicado: (2017)

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma
por: Li, Kang-Shuai, et al.
Publicado: (2020)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition
por: Ortiz-Zapater, Elena, et al.
Publicado: (2017)

Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): Recent insights using luminescence and fluorescence technologies
por: Kilpatrick, Laura E., et al.
Publicado: (2021)

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
por: Kim, Seongjae, et al.
Publicado: (2023)

microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway
por: Zhang, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sq80b5b9ca8iljakdma3hh9tlc